Cargando…

Skin Autofluorescence: A Pronounced Marker of Mortality in Hemodialysis Patients

BACKGROUND: Accelerated formation and tissue accumulation of advanced glycation endproducts (AGEs), reflecting cumulative glycemic and oxidative stress, occur in age-related and chronic diseases like diabetes mellitus (DM) and renal failure, and contribute to vascular damage. Skin autofluorescence (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerrits, Esther G., Lutgers, Helen L., Smeets, Gertie H.W., Groenier, Klaas H., Smit, Andries J., Gans, Reinold O.B., Bilo, Henk J.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398816/ https://www.ncbi.nlm.nih.gov/pubmed/22811692 http://dx.doi.org/10.1159/000339282

Ejemplares similares

Life Expectancy in a Large Cohort of Type 2 Diabetes Patients Treated in Primary Care (ZODIAC-10)
por: Lutgers, Helen L., et al.
Publicado: (2009)

Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up
por: van Dijk, Peter R, et al.
Publicado: (2014)

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2010)

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Health-Related Quality of Life and Mortality in a General and Elderly Population of Patients With Type 2 Diabetes (ZODIAC-18)
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2009)

Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28)
por: Gerrits, Esther G., et al.
Publicado: (2014)

Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease
por: Noordzij, Marjon J., et al.
Publicado: (2011)

Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15)
por: Landman, Gijs WD, et al.
Publicado: (2012)

Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2012)

Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population
por: van Waateringe, Robert P., et al.
Publicado: (2018)

Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
por: Roelofsen, Yvonne, et al.
Publicado: (2014)

Type 2 diabetes seems not to be a risk factor for the carpal tunnel syndrome: a case control study
por: Hendriks, Steven H, et al.
Publicado: (2014)

Glucose–insulin–potassium infusion in sepsis and septic shock: no hard evidence yet
por: van der Horst, Iwan CC, et al.
Publicado: (2003)

Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques
por: Drion, Iefke, et al.
Publicado: (2012)

Laser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomized, double-blind, controlled trial (LASER-1)
por: Nijenhuis-Rosien, Leonie, et al.
Publicado: (2015)

Skin Autofluorescence Based Decision Tree in Detection of Impaired Glucose Tolerance and Diabetes
por: Smit, Andries J., et al.
Publicado: (2013)

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2010)

Self-Monitoring of Blood Glucose: The Use of the First or the Second Drop of Blood
por: Hortensius, Johanna, et al.
Publicado: (2011)

Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
por: Kleefstra, Nanne, et al.
Publicado: (2009)

Favourable serum calcification propensity with intraperitoneal as compared with subcutaneous insulin administration in type 1 diabetes
por: van Dijk, Peter R., et al.
Publicado: (2020)

Randomized controlled trial on cardiovascular risk management by practice nurses supported by self-monitoring in primary care
por: Tiessen, Ans H, et al.
Publicado: (2012)

Which patient and treatment factors are related to successful cardiovascular risk score reduction in general practice? Results from a randomized controlled trial
por: Tiessen, Ans H, et al.
Publicado: (2013)

Plasma COOH-Terminal Proendothelin-1: A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)
por: Drion, Iefke, et al.
Publicado: (2012)

Increased Insulin Requirements During Exercise at Very High Altitude in Type 1 Diabetes
por: de Mol, Pieter, et al.
Publicado: (2011)

Skin Autofluorescence Is Associated with Endothelial Dysfunction in Uremic Subjects on Hemodialysis
por: Wang, Chun-Cheng, et al.
Publicado: (2016)

A non-invasive risk score including skin autofluorescence predicts diabetes risk in the general population
por: Boersma, Henderikus E., et al.
Publicado: (2022)

Lifestyle and clinical determinants of skin autofluorescence in a population‐based cohort study
por: van Waateringe, Robert P., et al.
Publicado: (2016)

A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort)
por: van de Zande, Saskia Corine, et al.
Publicado: (2022)

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35)
por: van Dijk, Peter R, et al.
Publicado: (2015)

Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot study
por: Atzeni, Isabella M., et al.
Publicado: (2020)

Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes
por: Boersma, Henderikus E., et al.
Publicado: (2021)

Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)
por: Fokkert, Marion, et al.
Publicado: (2019)

A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19)
por: van Hateren, Kornelis J J, et al.
Publicado: (2012)

Two-year use of flash glucose monitoring is associated with sustained improvement of glycemic control and quality of life (FLARE-NL-6)
por: Lameijer, Annel, et al.
Publicado: (2021)

Safety and Efficacy of Gliclazide as Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Trials
por: Landman, Gijs W. D., et al.
Publicado: (2014)

Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52)
por: Hendriks, Steven H., et al.
Publicado: (2018)

Metabolic Effects of High Altitude Trekking in Patients With Type 2 Diabetes
por: de Mol, Pieter, et al.
Publicado: (2012)

The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)
por: van Hateren, Kornelis J.J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gjugdfgceqr03a72m2rkstol2l